Preprint
- 20 June 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Not in the history of transmissible illnesses has there been an infection as strongly associated with acute cerebrovascular disease as the novel human coronavirus, SARS-CoV-2. While the risk of stroke has known associations with other viral infections, such as influenza and human immunodeficiency virus, the risk of ischemic and hemorrhagic stroke related to SARS-CoV-2 is unprecedented. Furthermore, the coronavirus disease 2019 (COVID-19) pandemic has so profoundly impacted psychosocial behaviors and modern medical care that we have witnessed shifts in epidemiology and have adapted our treatment practices to reduce transmission, address delayed diagnoses, and mitigate gaps in health care. In this narrative review, we summarize the history and impact of the COVID-19 pandemic on cerebrovascular disease, and lessons learned regarding the management of patients as we endure this period of human history.Keywords
All Related Versions
- Version 1, 2023-06-20, Preprints
- Published version: Viruses, 15 (7), 1598.
This publication has 51 references indexed in Scilit:
- No apparent association between mRNA COVID-19 vaccination and venous thromboembolismBlood Reviews, 2022
- Stroke Treatment in the Era of COVID-19: a ReviewCurrent Treatment Options in Neurology, 2022
- Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in SingaporeJAMA Network Open, 2022
- Public Perspectives on Decisions About Emergency Care Seeking for Care Unrelated to COVID-19 During the COVID-19 PandemicJAMA Network Open, 2021
- Correction to: Intracerebral Hemorrhage in COVID-19 Patients with Pulmonary Failure: A Propensity Score-Matched Registry StudyNeurocritical Care, 2021
- Identification of Functional Limitations and Discharge Destination in Patients With COVID-19Archives of Physical Medicine and Rehabilitation, 2021
- Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With InfluenzaJAMA Neurology, 2020
- Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patientsEBioMedicine, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Influenza‐like illness as a trigger for ischemic strokeAnnals of Clinical and Translational Neurology, 2018